Literature DB >> 12414958

Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction.

Bok-Soo Lee1, Mini Paulose-Murphy, Young-Hwa Chung, Michelle Connlole, Steven Zeichner, Jae U Jung.   

Abstract

The K1 protein of Kaposi's sarcoma-associated herpesvirus (KSHV) contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic region and elicits cellular signal transduction through this motif. To investigate the role of K1 signal transduction in KSHV replication, we expressed full-length K1 and CD8-K1 chimeras in BCBL1 cells. Unlike its strong signaling activity in uninfected B lymphocytes, K1 did not induce intracellular calcium mobilization or NF-AT activation at detectable levels in KSHV-infected BCBL1 cells. Instead, K1 signaling dramatically suppressed KSHV lytic reactivation induced by tetradecanoyl phorbol acetate (TPA) stimulation, but not by ORF50 ectopic expression. Mutational analysis showed that the cytoplasmic ITAM sequence of K1 was required for this suppression. Viral microarray and immunoblot analyses demonstrated that K1 signaling suppressed the TPA-mediated increase in the expression of a large subset of viral lytic genes in KSHV-infected BCBL1 cells. Furthermore, electrophoretic mobility shift assays demonstrated that TPA-induced activation of AP-1, NF-kappaB, and Oct-1 activities was severely diminished in BCBL1 cells expressing the K1 cytoplasmic domain. The reduced activities of these transcription factors may confer the observed reduction in viral lytic gene expression. These results demonstrate that K1-mediated signal transduction in KSHV-infected cells is profoundly different from that in KSHV-negative cells. Furthermore, K1 signal transduction efficiently suppresses TPA-mediated viral reactivation in an ITAM-dependent manner, and this suppression may contribute to the establishment and/or maintenance of KSHV latency in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414958      PMCID: PMC136871          DOI: 10.1128/jvi.76.23.12185-12199.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

Review 1.  Viral strategies of immune evasion.

Authors:  H L Ploegh
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

2.  Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?

Authors:  F Samaniego; S Pati; J E Karp; O Prakash; D Bose
Journal:  J Natl Cancer Inst Monogr       Date:  2001

3.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

5.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

Authors:  M A Cotter; E S Robertson
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

6.  An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.

Authors:  R Longnecker; B Druker; T M Roberts; E Kieff
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.

Authors:  B Chandran; M S Smith; D M Koelle; L Corey; R Horvat; E Goldstein
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

8.  Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes.

Authors:  S J Gao; Y J Zhang; J H Deng; C S Rabkin; O Flore; H B Jenson
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

9.  Identification of Lck-binding elements in tip of herpesvirus saimiri.

Authors:  J U Jung; S M Lang; U Friedrich; T Jun; T M Roberts; R C Desrosiers; B Biesinger
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

10.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.

Authors:  M Li; H Lee; J Guo; F Neipel; B Fleckenstein; K Ozato; J U Jung
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  23 in total

1.  Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.

Authors:  Yao Chang; Heng-Huan Lee; Shih-Shin Chang; Tsuey-Ying Hsu; Pei-Wen Wang; Yu-Sun Chang; Kenzo Takada; Ching-Hwa Tsai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

3.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.

Authors:  Subhash C Verma; Ke Lan; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.

Authors:  Zhigang Zhang; Wuguo Chen; Marcia K Sanders; Kevin F Brulois; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

5.  Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  Sanjay Chandriani; Don Ganem
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  T L Morris; R R Arnold; J Webster-Cyriaque
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome.

Authors:  Bok-Soo Lee; Sun-Hwa Lee; Pinghui Feng; Heesoon Chang; Nam-Hyuk Cho; Jae U Jung
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

Authors:  Zuzana Berkova; Shu Wang; Jillian F Wise; Hoyoung Maeng; Yuan Ji; Felipe Samaniego
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

9.  A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation.

Authors:  Andreas Konrad; Effi Wies; Mathias Thurau; Gaby Marquardt; Elisabeth Naschberger; Sonja Hentschel; Ramona Jochmann; Thomas F Schulz; Holger Erfle; Benedikt Brors; Berthold Lausen; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

10.  The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway.

Authors:  Christine C Tomlinson; Blossom Damania
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.